Navin Fluorine International Limited has informed the Exchange about Schedule of meet and Presentation
NAVINFLUOR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Navin Fluorine has informed exchanges about a one-on-one analyst and institutional investor meet scheduled from June 23 to June 30, 2025. The filing includes the May 2025 investor presentation with full-year and Q4FY25 results. FY25 consolidated sales grew 14% YoY to Rs. 2,349.4 Crs, operating EBITDA jumped 34% to Rs. 533.7 Crs with margin expansion of 343 bps to 22.7%, and operating PBT rose 48% to Rs. 336.4 Crs. Q4FY25 was even stronger with sales up 16% YoY to Rs. 700.9 Crs and EBITDA margin reaching 25.5% (+721 bps YoY). The CDMO vertical surged 141% YoY in Q4, while HPP grew 26% in FY25. Key updates include a new Chemours partnership for data center cooling fluids ($14MN capex, operational by Q1FY27), AHF plant commissioning targeted for Q2FY26, and cGMP4 Phase 1 commissioning by end of Q3FY26. The company reported Net D/E of 0.37x and operating cash flow of Rs. 571 Crs, while continuing its track record of consistent dividends with a 250% payout in FY25.
This is a routine regulatory disclosure for an investor meet, not a new corporate action, so no direct stock price impact is expected. However, the accompanying presentation reaffirms a strong earnings trajectory with margin expansion, robust growth in the high-value CDMO segment, and a healthy pipeline of capacity and partnership announcements — all of which support a positive long-term outlook for shareholders.